Limosilactobacillus reuteri in Health and Disease

52Citations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

Limosilactobacillus reuteri is a microorganism with valuable probiotic qualities that has been widely employed in humans to promote health. It is a well-studied probiotic bacterium that exerts beneficial health effects due to several metabolic mechanisms that enhance the production of anti-inflammatory cytochines and modulate the gut microbiota by the production of antimicrobial molecules, including reuterin. This review provides an overview of the data that support the role of probiotic properties, and the antimicrobial and immunomodulatory effects of some L. reuteri strains in relation to their metabolite production profile on the amelioration of many diseases and disorders. Although the results discussed in this paper are strain dependent, they show that L. reuteri, by different mechanisms and various metabolites, may control body weight and obesity, improve insulin sensitivity and glucose homeostasis, increase gut integrity and immunomodulation, and attenuate hepatic disorders. Gut microbiota modulation by ingesting probiotic L. reuteri strains could be a promising preventative and therapeutic approach against many diseases and disorders.

References Powered by Scopus

Pattern Recognition Receptors and Inflammation

7004Citations
N/AReaders
Get full text

Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic

6776Citations
N/AReaders
Get full text

Metabolic endotoxemia initiates obesity and insulin resistance

5101Citations
N/AReaders
Get full text

Cited by Powered by Scopus

In vitro fermentation characteristics of polysaccharides from coix seed and its effects on the gut microbiota

15Citations
N/AReaders
Get full text

Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation

12Citations
N/AReaders
Get full text

Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Abuqwider, J., Altamimi, M., & Mauriello, G. (2022, March 1). Limosilactobacillus reuteri in Health and Disease. Microorganisms. MDPI. https://doi.org/10.3390/microorganisms10030522

Readers over time

‘22‘23‘24‘25015304560

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

70%

Lecturer / Post doc 3

15%

Researcher 2

10%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 8

44%

Agricultural and Biological Sciences 4

22%

Medicine and Dentistry 4

22%

Chemistry 2

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
Social Media
Shares, Likes & Comments: 113

Save time finding and organizing research with Mendeley

Sign up for free
0